Patterns of acquisitive crime during methadone maintenance treatment among patients eligible for heroin assisted treatment

Zanden, Bart P. van der; Dijkgraaf, Marcel G. W.; Blanken, Peter; Ree, Jan M. van; Brink, Wim van den

doi:10.1016/j.drugalcdep.2006.05.021

Cited by 23 publications

(14 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This is especially the case for drug treatment and mental health services in prisons, where a lack of communication and "silo working" between the two services frequently hampers treatment progress ( The finding that heroin and cocaine use was associated with an increased risk of recidivism implies a need to prioritise these risk factors in the assessment and through care planning within substance dependency treatment programmes (Kopak et al, 2014). Especially as these drugs have been associated with an increased risk of acquisitive offences (Bennett and Holloway, 2005;van der Zanden et al, 2007). Treatment efforts to reduce heroin use have been associated with reductions in acquisitive crime (Gossop et al, 2000), which has been identified, in the current UK criminal justice climate, as a key area to target in order to reduce reoffending (Drugs: Protecting Families and Communities, 2008).…”

Section: Discussionmentioning

confidence: 99%

Predicting recidivism for offenders in UK substance dependence treatment: do mental health symptoms matter?

Breedvelt¹,

Dean²,

Jones³

et al. 2014

Journal of Criminal Psychology

View full text Add to dashboard Cite

2014),"Features and motivators of emotionally expressive firesetters: the assessment of women in secure psychiatric settingsIf you would like to write for this, or any other Emerald publication, then please use our Emerald for Authors service information about how to choose which publication to write for and submission guidelines are available for all. Please visit www.emeraldinsight.com/authors for more information. About Emerald www.emeraldinsight.comEmerald is a global publisher linking research and practice to the benefit of society. The company manages a portfolio of more than 290 journals and over 2,350 books and book series volumes, as well as providing an extensive range of online products and additional customer resources and services.Emerald is both COUNTER 4 and TRANSFER compliant. The organization is a partner of the Committee on Publication Ethics (COPE) and also works with Portico and the LOCKSS initiative for digital archive preservation. AbstractPurpose -The purpose of this paper is to assess whether mental health symptoms affect one-year reoffending rates upon release from prison for participants engaging in substance dependence treatment in the UK. Design/methodology/approach -A retrospective cohort study was used to assess reconviction outcomes upon release. The Comprehensive Addiction and Psychological Evaluation (CAAPE) was administered to 667 inmates admitted to the programme. The effect of mental health, drug use, and static risk factors on reoffending was assessed at one-year post release. Findings -Logistic regression analysis showed that symptoms of Major Depressive Disorder at the start of substance dependence treatment increased the likelihood to reoffend, whilst Obsessive Compulsive Disorder symptoms and length of sentence decreased the likelihood to reoffend. Antisocial Personality Disorder symptoms show a trend towards increasing the likelihood to reoffend. In addition, previously established risk factors for reoffending, including dependence on heroin, crack/cocaine, and poly drug use significantly increased the likelihood of reconviction. Practical implications -Depressive symptomatology pre-treatment could affect reoffending outcomes for participants in substance dependence treatment in prison. An integrative approach addressing both substance misuse and mental health factors is pivotal. Future efforts to address both simultaneously can be made to improve assessment, training, treatment, and through care for prisoners in substance dependence treatment. Originality/value -Few studies have assessed the effect of mental health factors on reoffending outcomes for offenders in substance dependence treatment. A large sample was studied in an understudied population of UK prisoners in substance dependence treatment. The results have implications for clinical settings where mental health symptoms are not addressed concurrently with substance dependence. This finding can inform policy makers and practitioners who provide substance dependence treatment in prison.

show abstract

Section: Discussionmentioning

confidence: 99%

Predicting recidivism for offenders in UK substance dependence treatment: do mental health symptoms matter?

Breedvelt¹,

Dean²,

Jones³

et al. 2014

Journal of Criminal Psychology

View full text Add to dashboard Cite

show abstract

“…Chronic opioid use disorder (OUD), particularly the injection of illicit street opioids, is known to exact a number of harms on the individual, including the risk of infectious disease such as human immunodeficiency virus (HIV) and hepatitis C (HCV), as well as the risk of fatal and non-fatal overdose, social disintegration, violence and incarceration ( Roxburgh, Darke, Salmon, Dobbins, & Jauncey, 2017 ; van der Zanden, Dijkgraaf, Blanken, van Ree, & van den Brink, 2007 ). The burden of chronic opioid use disorder on communities includes death, public disorder, and health and criminal justice costs ( Birnbaum et al, 2011 ).…”

Section: Introductionmentioning

confidence: 99%

The association between nicotine dependence and physical health among people receiving injectable diacetylmorphine or hydromorphone for the treatment of chronic opioid use disorder

Palis

Marchand

Karamouzian

et al. 2018

Addictive Behaviors Reports

View full text Add to dashboard Cite

IntroductionPeople with chronic opioid use disorder often present to treatment with individual and structural vulnerabilities and remain at risk of reporting adverse health outcomes. This risk is greatly compounded by tobacco smoking, which is highly prevalent among people with chronic opioid use disorder. Despite the known burden of tobacco smoking on health, the relationship between nicotine dependence and health has not been studied among those receiving injectable opioid agonist treatment. As such, the present study aims to explore the association between nicotine dependence and physical health among participants of the Study to Assess Longer-Term Opioid Medication Effectiveness (SALOME) at baseline and six-months.MethodsSALOME was a double-blind phase III clinical trial testing the non-inferiority of injectable hydromorphone to injectable diacetylmorphine for chronic opioid use disorder. Participants reporting tobacco smoking were included in a linear regression analysis of physical health at baseline (before receiving treatment) and at six-months.ResultsAt baseline, nicotine dependence score, lifetime history of emotional, physical, or sexual abuse and prior month safe injection site access were independently and significantly associated with physical health. At six-months nicotine dependence score was the only variable that maintained this significant and independent association with physical health.ConclusionsFindings indicate that after six-months, the injectable treatment effectively brought equity to patients' physical health status, yet the association with nicotine dependence remained. Findings could inform whether the provision of treatment for nicotine dependence should be made a priority in settings where injectable opioid agonist treatment is delivered to achieve improvements in overall physical health in this population.

show abstract

“…Observance of high-risk substance use situations and possibly the connections between substance use and criminal activity are some initial relapse prevention approaches that should be taken with this special population (Marlatt and Witkiewitz, 2005). This will be most important for patients treated for drug dependence who may be likely to engage in economically motivated crime to finance their drug use (Gudjonsson et al, 2011;van der Zanden et al, 2007). This point was recently underscored by results which demonstrated that individuals who participated in substance use treatment and were given a basic work opportunity had significantly lower rates of arrest for predatory economically driven offending, such as robbery and burglary (Uggen and Shannon, 2014).…”

Section: Discussionmentioning

confidence: 99%

Indicators of rearrest among male court mandated substance use treatment patients

Kopak

Proctor

Hoffmann

2016

Journal of Criminological Research, Policy and Practice

View full text Add to dashboard Cite

If you would like to write for this, or any other Emerald publication, then please use our Emerald for Authors service information about how to choose which publication to write for and submission guidelines are available for all. Please visit www.emeraldinsight.com/authors for more information. About Emerald www.emeraldinsight.comEmerald is a global publisher linking research and practice to the benefit of society. The company manages a portfolio of more than 290 journals and over 2,350 books and book series volumes, as well as providing an extensive range of online products and additional customer resources and services.Emerald is both COUNTER 4 and TRANSFER compliant. The organization is a partner of the Committee on Publication Ethics (COPE) and also works with Portico and the LOCKSS initiative for digital archive preservation. AbstractPurpose -Effective substance use treatment is a viable way to reduce criminal justice contact among drug-involved offenders, but there is still a lot to learn about which indicators have the greatest impact on treatment outcomes. The purpose of this paper is to determine which clinical indicators influenced the likelihood of rearrest among male drug-involved offenders. Design/methodology/approach -This prospective longitudinal study examined indicators of 12-month post-treatment rearrest for male criminal justice-involved substance use treatment patients. Multinomial logistic regression results drawn from a sample of 1,531 adult male patients who were mandated to substance use treatment indicated that there were different factors related to the likelihood of one as well as multiple post-treatment arrests. Findings -Demographic risk factors, such as age and unemployment, were associated with significant increases in the probability of experiencing an arrest within 12-months of treatment discharge. Substance use relapse was also a significant indicator of the likelihood of rearrest and contributed to an increase in the odds of one post-treatment rearrest as well as multiple rearrests. A drug dependence diagnosis, relative to a diagnosis for alcohol dependence, was associated with an increased likelihood of rearrest. Participation in outpatient treatment was associated with a lower likelihood of rearrest. Practical implications -These findings emphasize the need for treatment providers to concentrate heavily on demographic risk reduction to minimize the chance that male patients are rearrested after treatment. Relapse prevention, on the other hand, is critical in the effort to minimize the number of post-treatment rearrests in this population. Originality/value -The results from this study provide evidence to empirically support the refinement of substance treatment programs for male patients involved in the criminal justice system.

show abstract

Patterns of acquisitive crime during methadone maintenance treatment among patients eligible for heroin assisted treatment

Cited by 23 publications

References 16 publications

Predicting recidivism for offenders in UK substance dependence treatment: do mental health symptoms matter?

Predicting recidivism for offenders in UK substance dependence treatment: do mental health symptoms matter?

The association between nicotine dependence and physical health among people receiving injectable diacetylmorphine or hydromorphone for the treatment of chronic opioid use disorder

Indicators of rearrest among male court mandated substance use treatment patients

Contact Info

Product

Resources

About